265 related articles for article (PubMed ID: 20508983)
1. Centrosome-related genes, genetic variation, and risk of breast cancer.
Olson JE; Wang X; Pankratz VS; Fredericksen ZS; Vachon CM; Vierkant RA; Cerhan JR; Couch FJ
Breast Cancer Res Treat; 2011 Jan; 125(1):221-8. PubMed ID: 20508983
[TBL] [Abstract][Full Text] [Related]
2. Variation in genes required for normal mitosis and risk of breast cancer.
Olson JE; Wang X; Goode EL; Pankratz VS; Fredericksen ZS; Vierkant RA; Pharoah PD; Cerhan JR; Couch FJ
Breast Cancer Res Treat; 2010 Jan; 119(2):423-30. PubMed ID: 19377877
[TBL] [Abstract][Full Text] [Related]
3. Association of genetic variation in mitotic kinases with breast cancer risk.
Wang X; Fredericksen ZS; Vierkant RA; Kosel ML; Pankratz VS; Cerhan JR; Justenhoven C; Brauch H; ; Olson JE; Couch FJ
Breast Cancer Res Treat; 2010 Jan; 119(2):453-62. PubMed ID: 19404734
[TBL] [Abstract][Full Text] [Related]
4. Impact of genetic polymorphisms in base excision repair genes on the risk of breast cancer in a Korean population.
Kim KY; Han W; Noh DY; Kang D; Kwack K
Gene; 2013 Dec; 532(2):192-6. PubMed ID: 24076439
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer risk associated with genotypic polymorphism of the mitosis-regulating gene Aurora-A/STK15/BTAK.
Lo YL; Yu JC; Chen ST; Yang HC; Fann CS; Mau YC; Shen CY
Int J Cancer; 2005 Jun; 115(2):276-83. PubMed ID: 15688402
[TBL] [Abstract][Full Text] [Related]
6. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
[TBL] [Abstract][Full Text] [Related]
8. Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer.
Garcia-Closas M; Kristensen V; Langerød A; Qi Y; Yeager M; Burdett L; Welch R; Lissowska J; Peplonska B; Brinton L; Gerhard DS; Gram IT; Perou CM; Børresen-Dale AL; Chanock S
Int J Cancer; 2007 Dec; 121(11):2532-8. PubMed ID: 17683073
[TBL] [Abstract][Full Text] [Related]
9. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21.
Hamdi Y; Soucy P; Adoue V; Michailidou K; Canisius S; Lemaçon A; Droit A; Andrulis IL; Anton-Culver H; Arndt V; Baynes C; Blomqvist C; Bogdanova NV; Bojesen SE; Bolla MK; Bonanni B; Borresen-Dale AL; Brand JS; Brauch H; Brenner H; Broeks A; Burwinkel B; Chang-Claude J; ; Couch FJ; Cox A; Cross SS; Czene K; Darabi H; Dennis J; Devilee P; Dörk T; Dos-Santos-Silva I; Eriksson M; Fasching PA; Figueroa J; Flyger H; García-Closas M; Giles GG; Goldberg MS; González-Neira A; Grenaker-Alnæs G; Guénel P; Haeberle L; Haiman CA; Hamann U; Hallberg E; Hooning MJ; Hopper JL; Jakubowska A; Jones M; Kabisch M; Kataja V; Lambrechts D; Le Marchand L; Lindblom A; Lubinski J; Mannermaa A; Maranian M; Margolin S; Marme F; Milne RL; Neuhausen SL; Nevanlinna H; Neven P; Olswold C; Peto J; Plaseska-Karanfilska D; Pylkäs K; Radice P; Rudolph A; Sawyer EJ; Schmidt MK; Shu XO; Southey MC; Swerdlow A; Tollenaar RA; Tomlinson I; Torres D; Truong T; Vachon C; Van Den Ouweland AM; Wang Q; Winqvist R; ; Zheng W; Benitez J; Chenevix-Trench G; Dunning AM; Pharoah PD; Kristensen V; Hall P; Easton DF; Pastinen T; Nord S; Simard J
Oncotarget; 2016 Dec; 7(49):80140-80163. PubMed ID: 27792995
[TBL] [Abstract][Full Text] [Related]
10. Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study.
Tinholt M; Viken MK; Dahm AE; Vollan HK; Sahlberg KK; Garred O; Børresen-Dale AL; Jacobsen AF; Kristensen V; Bukholm I; Kåresen R; Schlichting E; Skretting G; Lie BA; Sandset PM; Iversen N
BMC Cancer; 2014 Nov; 14():845. PubMed ID: 25407022
[TBL] [Abstract][Full Text] [Related]
11. Association of SNP-SNP Interactions Between RANKL, OPG, CHI3L1, and VDR Genes With Breast Cancer Risk in Egyptian Women.
Shaker OG; Senousy MA
Clin Breast Cancer; 2019 Feb; 19(1):e220-e238. PubMed ID: 30309792
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects.
Nyante SJ; Gammon MD; Kaufman JS; Bensen JT; Lin DY; Barnholtz-Sloan JS; Hu Y; He Q; Luo J; Millikan RC
Cancer Causes Control; 2015 Jan; 26(1):121-31. PubMed ID: 25421376
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs.
Li N; Rowley SM; Thompson ER; McInerny S; Devereux L; Amarasinghe KC; Zethoven M; Lupat R; Goode D; Li J; Trainer AH; Gorringe KL; James PA; Campbell IG
Breast Cancer Res; 2018 Jan; 20(1):3. PubMed ID: 29316957
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of associations between common variation in mitotic regulatory pathways and risk of overall and high grade breast cancer.
Stevens KN; Wang X; Fredericksen Z; Pankratz VS; Cerhan J; Vachon CM; Olson JE; Couch FJ
Breast Cancer Res Treat; 2011 Sep; 129(2):617-22. PubMed ID: 21607584
[TBL] [Abstract][Full Text] [Related]
15. Association of the progesterone receptor gene with breast cancer risk: a single-nucleotide polymorphism tagging approach.
Pooley KA; Healey CS; Smith PL; Pharoah PD; Thompson D; Tee L; West J; Jordan C; Easton DF; Ponder BA; Dunning AM
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):675-82. PubMed ID: 16614108
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women.
Gaudet MM; Chanock S; Lissowska J; Berndt SI; Yang XR; Peplonska B; Brinton LA; Welch R; Yeager M; Bardin-Mikolajczak A; Sherman ME; Sutter TR; Garcia-Closas M
Pharmacogenet Genomics; 2006 Aug; 16(8):547-53. PubMed ID: 16847423
[TBL] [Abstract][Full Text] [Related]
17. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Chen YC; Kraft P; Bretsky P; Ketkar S; Hunter DJ; Albanes D; Altshuler D; Andriole G; Berg CD; Boeing H; Burtt N; Bueno-de-Mesquita B; Cann H; Canzian F; Chanock S; Dunning A; Feigelson HS; Freedman M; Gaziano JM; Giovannucci E; Sánchez MJ; Haiman CA; Hallmans G; Hayes RB; Henderson BE; Hirschhorn J; Kaaks R; Key TJ; Kolonel LN; LeMarchand L; Ma J; Overvad K; Palli D; Pharaoh P; Pike M; Riboli E; Rodriguez C; Setiawan VW; Stampfer M; Stram DO; Thomas G; Thun MJ; Travis RC; Virtamo J; Trichopoulou A; Wacholder S; Weinstein SJ
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1973-81. PubMed ID: 17932344
[TBL] [Abstract][Full Text] [Related]
18. Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population.
Marouf C; Göhler S; Filho MI; Hajji O; Hemminki K; Nadifi S; Försti A
BMC Cancer; 2016 Feb; 16():165. PubMed ID: 26920143
[TBL] [Abstract][Full Text] [Related]
19. Functional genetic variants in centrosome-related genes CEP72 and YWHAG confer susceptibility to gastric cancer.
Ni J; Wang J; Fu Y; Yan C; Zhu M; Jiang Y; Chen J; Ding Y; Fan X; Li G; Jin G
Arch Toxicol; 2020 Aug; 94(8):2861-2872. PubMed ID: 32535685
[TBL] [Abstract][Full Text] [Related]
20. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.
Pearce CL; Hirschhorn JN; Wu AH; Burtt NP; Stram DO; Young S; Kolonel LN; Henderson BE; Altshuler D; Pike MC
J Natl Cancer Inst; 2005 Jan; 97(1):51-9. PubMed ID: 15632380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
